Abstract

The fibronectin leucine rich transmembrane (FLRT) protein family consists in humans of 3 proteins, FLRT1, -2, and -3. The FLRT proteins contain two extracellular domains separated by an unstructured linker. The most membrane distal part is a leucine rich repeat (LRR) domain responsible for both cis- and trans-interactions, whereas the membrane proximal part is a fibronectin type III (FnIII) domain responsible for a cis-interaction with members of the fibroblast growth factor receptor 1 (FGFR1) family, which results in FGFR tyrosine kinase activation. Whereas the structures of FLRT LRR domains from various species have been determined, the expression and purification of recombinant FLRT FnIII domains, important steps for further structural and functional characterizations of the proteins, have not yet been described. Here we present a protocol for expressing recombinant FLRT-FnIII domains in inclusion bodies in Escherichia coli. His-tags permitted affinity purification of the domains, which subsequently were refolded on a Ni-NTA agarose column by reducing the concentration of urea. The refolding was confirmed by circular dichroism (CD) and 1H-NMR. By thermal unfolding experiments we show that a strand-strand cystine bridge has significant effect on the stability of the FLRT FnIII fold. We further show by Surface Plasmon Resonance that all three FnIII domains bind to FGFR1, and roughly estimate a Kd for each domain, all Kds being in the µM range.

Highlights

  • The fibronectin leucine rich transmembrane (FLRT) protein family was first described in 1999

  • We present a protocol for expression and on-column refolding of FLRT fibronectin type III (FnIII) domains

  • It can be concluded that on-column refolding of FLRTs-FnIII domains can be performed successfully as seen from circular dichroism (CD) experiments and NMR studies, and that protease inhibitors should be included in future studies, since the domains are prone to cleavage

Read more

Summary

INTRODUCTION

The fibronectin leucine rich transmembrane (FLRT) protein family was first described in 1999. FGFR are implicated in a number of diseases including cancer, schizophrenia and Parkinson’s disease (Jin et al, 2005; Krejci et al, 2009; Turner & Grose, 2010; Haugsten et al, 2010; Van Scheltinga, Bakker & Kahn, 2010) In addition to their interaction with FGFs, the extracellular domains of FGFRs can bind several proteins located in the plasma membrane, including a number of cell adhesion molecules among which FLRTs. The FnIII domain of Xenopus FLRT3 (XFLRT3) is reported to bind directly to FGFR1 (Böttcher et al, 2004), and a later study has demonstrated that all three mouse FLRTs act as regulators of FGFR-mediated signaling through direct interaction with FGFR1 independently of prior FGFR activation (Haines et al, 2006). One aim of the study was to eventually produce deuterated proteins suitable for small angle neutron scattering, and Escherichia coli was chosen as an expression system

MATERIALS AND METHODS
AND DISCUSSION
Findings
CONCLUSION
Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call